Skip to main content

Advertisement

SpringerLink
Log in

The skin: a mirror to the gut

  • Review
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Introduction

This review discusses the diseases with involvement of both skin and gut. GI manifestations of vesicobullous disorders and systemic diseases and syndromes involving skin and gut, dermatologic manifestations of inflammatory bowel disease (IBD), polyposis syndromes, and GI malignancies have been discussed. Diagnostic and treatment approaches towards these disorders are summarized.

Conclusions

Interaction of the skin and gut has always been an area of inquisitiveness. Gastrointestinal (GI) tract can be involved in dermatological disorders or GI diseases can have a dermatological manifestation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Mirowski GW, Mark LA. Oral disease and oral–cutaneous manifestations of gastrointestinal and liver disease. In: Sleisenger and Fordtran’s Gastrointestinal and liver disease. Volume 1. 8th ed. Philadelphia: Saunders, 2006: 443-463

  2. KO CJ. Dermatologic manifestations of gastrointestinal disease. In: emedicine.medscape.com/article/1093801-overview.

  3. Lorizzo M, Jorizzo JL. Skin lesions associated with gastrointestinal and liver diseases. In: Textbook of gastroenterology. Volume 2. 5th ed. Oxford: Wiley-Blackwell, 2009: 2755-2784.

  4. Fine DJ (2010) Inherited epidermolysis bullosa. Orphanet J rare dis 5(1):12–28

    Article  PubMed  Google Scholar 

  5. Rook EA, Wilkinson DS, Ebling FJB et al. Epidermolysis bullosa. In: Textbook of dermatology. Volume 2. 8th ed. Oxford: Blackwell, 2010: 39.1-39.28.

  6. Daniels TE, Quadra-White C (1981) Direct immunofluorescence in oral mucosal disease: a diagnostic analysis of 130 cases. Oral Surg Oral Med Oral Pathol 51(1):38–47

    Article  PubMed  CAS  Google Scholar 

  7. Korman NJ (2000) New and emerging therapies in the treatment of blistering diseases. Dermatol Clin 18(1):127–37, ix-x

    Article  PubMed  CAS  Google Scholar 

  8. Kasperkiewicz M, Schmidt E (2009) Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol 6(4):270–280

    Article  PubMed  CAS  Google Scholar 

  9. Troiano M, Lotti T (2009) Rituximab in dermatological diseases. G Ital Dermatol Venerol 144(4):495–499

    CAS  Google Scholar 

  10. Zeina B, Kakka N, Mansoor S. Pemphigus vulgaris. In: emedicine.medscape.com/article/1064187-overview.

  11. Goldberg LJ, Nisar N. Paraneoplastic pemphigus. In: emedicine.medscape.com/article/1064452-overview.

  12. Anhalt GJ, Kim SC, Stanely JR et al (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323(5):1729–1735

    Article  PubMed  CAS  Google Scholar 

  13. Chapel TA, Chapel J (1996) Erythema multiforme. In: Tintinalli J et al (eds) Emergency medicine: a comprehensive study guide, 4th edn. McGraw Hill, New York, pp 1114–1116

    Google Scholar 

  14. Parrillo SJ. Stevens–Johnson Syndrome. In: emedicine.medscape.com/article/756523-overview.

  15. Yamane Y, Aihara M, Tatewaki S et al (2009) Analysis of treatments and deceased cases of severe adverse drug reactions—analysis of 46 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis. Arerugi 58(5):537–47

    PubMed  Google Scholar 

  16. Gilliand BC (1998) Systemic sclerosis. In: Braunwald E, Longo DL et al (eds) Harrison’s principles of internal medicine, 14th edn. McGraw-Hill, New York, pp 1888–1895

    Google Scholar 

  17. Jimenez SA. Scleroderma. In: emedicine.medscape.com/article/331864-overview.

  18. Wegener M, Adamek RJ, Wedmann B et al (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39(10):2209–15

    Article  PubMed  CAS  Google Scholar 

  19. Fries R, Shariat K, con Wilmowski et al (2005) Sildenafil in the treatment of Raynaud phenomenon resistant to vasodilator therapy. Circulation 112(19):2980–2985

    PubMed  CAS  Google Scholar 

  20. Sallam H, McNearney TA, Doshi D et al (2007) Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci 52(5):1329–37

    Article  PubMed  Google Scholar 

  21. Westermark P, Benson MD, Buxbaum JM et al (2008) A primer of amyloid nomenclature. Amyloid 14(3):179–183

    Article  CAS  Google Scholar 

  22. Kyle RA, Greipp PR (1983) Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 58(10):665–83

    PubMed  CAS  Google Scholar 

  23. Ebert EC, Nagar M (2008) Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 103(3):776–87

    Article  PubMed  Google Scholar 

  24. Wong CK, Wang WJ (1994) Systemic amyloidosis: a report of 19 cases. Dermatology 189(1):47–51

    Article  PubMed  CAS  Google Scholar 

  25. Uitto J, Shamban A (1987) Heritable skin diseases with molecular defect in collagen or elastin. Dermatol Clin 5(1):63–84

    PubMed  CAS  Google Scholar 

  26. Sahata T, Tsuda S, Abo M et al (2009) Ehlers–Danlos syndrome with a frequent intestinal perforation. Nippon Nalka Gakkai Zasshi 98(4):852–4

    Article  Google Scholar 

  27. Beighton P (1972) The dominant and recessive forms of cutis laxa. J Med Genet 9(2):216–21

    Article  PubMed  CAS  Google Scholar 

  28. Mulvihill JJ, Parry DM, Sherman JL et al (1990) NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neuro-fibromatosis 2 (bilateral acoustic neurofibromatosis): an update. Ann Intern Med 113(1):39–52

    Article  PubMed  CAS  Google Scholar 

  29. DeBella K, Szudek J, Friedman JM (2000) Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105(3 Pt 1):608–614

    Article  PubMed  CAS  Google Scholar 

  30. Cameron AJ, Pairolero PC, Stanson AW et al (1982) Abdominal angina and neurofibromatosis. Mayo Clin Proc 57(2):125–8

    PubMed  CAS  Google Scholar 

  31. Stamm B, Hedinger CE, Saremaslani P: Duodenal and ampullary carcinoid tumors: a report of 12 cases with pathological characteristics, polypeptide content, and relation to the MEN I syndrome and von Recklinghausen’s disease (neurofibromatosis). Virchows Arch A Pathol Anat Histopathol; 408(5): 475–89

  32. South CD, Baird MA, Marsh WL Jr (2009) Clinical challenges and images in GI. Ampullary somatostatinoma associated with neurofibromatosis type 1, presenting with iron-deficiency anemia. Gastroenterology 136(1):51–368

    Article  PubMed  Google Scholar 

  33. Hengge UR, Ruzicka T, Tyring SK et al (2002) Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part1: epidemiology, environment predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2(5):281–92

    Article  PubMed  Google Scholar 

  34. Gandhi M, Greenblatt RM (2002) Human herpes virus 8, Kaposi’s sarcoma, and associated conditions. Clin Lab Med 22(4):883–910

    Article  PubMed  Google Scholar 

  35. Danzing JB, Brandt LJ, Reinus JF et al (1991) Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 86(6):715–718

    Google Scholar 

  36. Parfitt JR, Rodriguez-Justo M, Feakins R et al (2008) Gastrointestinal Kaposi’s sarcoma: CD 117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour. Histopathology 52(7):816–823

    Article  PubMed  CAS  Google Scholar 

  37. Schwartz RA. Osler–Weber–Rendu syndrome. In: emedicine.medscape.com/article/1086114-overview.

  38. Shovlin CL, Hughes JM, Scott J et al (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61(1):68–79

    Article  PubMed  CAS  Google Scholar 

  39. Kjeldsen AD, Kjeldsen J (2000) Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 95(2):415–418

    Article  PubMed  CAS  Google Scholar 

  40. Shields H, Shaffer K, O’farrell RP et al (2007) Gastrointestinal manifestations of dermatologic disorders. Clin Gastroenterol Hepatol 5(9):1010–7, quiz 1005-1006

    Article  PubMed  Google Scholar 

  41. Milot L, Kamaoui I, Gautier G et al (2008) Hereditary–hemorrhagic telangiectasia: one-step magnetic resonance examination in evaluation of liver involvement. Gastroenterol Clin Biol 32(8–9):677–685

    Article  PubMed  CAS  Google Scholar 

  42. Fritzler MJ, Arlette JP, Behm AR et al (1984) Hereditary hemorrhagic telangiectasia versus CREST syndrome: can serology aid diagnosis? J Am Acad Dermatol 10(2 Pt 1):192–6

    Article  PubMed  CAS  Google Scholar 

  43. Van Cutsem E, Rutgeerts P, Vantrappen G (1990) Treatment of bleeding gastrointestinal vascular malformations with oestrogen–progesterone. Lancet 335(8695):953–5

    Article  PubMed  Google Scholar 

  44. Longacre AV, Gross CP, Gallitelli M et al (2003) Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 98(1):59–65

    Article  PubMed  Google Scholar 

  45. Cherpelis BS. Fenske NA. Blue rubber bleb nevus syndrome. In: emedicine.medscape.com/article/1082839-overview.

  46. Tyrrel RT, Baumgartner BR, Montemayor KA (1990) Blue rubber bleb nevus syndrome: CT diagnosis of intussusception. AJR Am J Roentgenol 154(1):105–6

    Article  PubMed  CAS  Google Scholar 

  47. Emami MH, Haghdani S, Tavakkoli H et al (2008) Endoscopic polypectomy resection of blue rubber bleb nevus lesions in small bowel. Indian J Gastroenterol 27(4):165–6

    PubMed  Google Scholar 

  48. Scheinfeld NS. Degos disease. In: emedicine.medscape.com/article/1087180-overview.

  49. High WA, Aranda J, Patel SB et al (2004) Is Degos disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol 50(6):895–899

    Article  PubMed  Google Scholar 

  50. Ball E, Newburger A, Ackerman AB (2004) Degos disease: a distinctive pattern of disease, chiefly of lupus erythematosus, and not a specific disease per se. Am J Dermatopathol 24(4):308–320

    Google Scholar 

  51. Guhl G, Diaz-Ley B, Delgado Y et al (2009) Wegener’s granulomatosis: a new entity in the growing differential diagnosis of Degos' disease. Clin Exp Dermatol 34(5):e1–3

    Article  PubMed  CAS  Google Scholar 

  52. Degos R (1979) Malignant atrophic papulosis. Br J Dermatol 100(1):21–35

    Article  PubMed  CAS  Google Scholar 

  53. Magro C, Shapiro L, Johnson B et al. Rheumatology grand rounds hospital for special surgery (New York City) Degos Disease. Feb 10, 2010. In press.

  54. Janniger CK (2006) Klippel–Trenaunay–Weber syndrome: differential diagnosis and workup. In: emedicine.medscape.com/article/1084257-overview. Int J Dermatol 45(8):883–90

    Article  PubMed  Google Scholar 

  55. Bliznak J, Staple TW (1974) Radiology of angiodysplasias of the limb. Radiology 110(1):35–44

    PubMed  CAS  Google Scholar 

  56. Servelle M (1985) Klippel and Trenaunay’s syndrome. 768 operated cases. Ann Surg 201(3):365–373

    Article  PubMed  CAS  Google Scholar 

  57. Baskerville PA, Ackroyd JS, Browse NL (1985) The etiology of the Klippel–Trenaunay syndrome. Ann Surg 202(5):624–627

    Article  PubMed  CAS  Google Scholar 

  58. McGrory BJ, Amadio PC (1993) Klippel–Trenaunay syndrome: orthopaedic considerations. Orthop Rev 22(1):41–50

    PubMed  CAS  Google Scholar 

  59. Janniger CK. Klippel–Trenaunay–Weber syndrome. In: emedicine.medscape.com/article/1084257-overview.

  60. Wang ZK, Wang FY, Zhu RM et al (2010) Klippel–Trenaunay syndrome with gastrointestinal bleeding, splenic hemangiomas and left inferior vena cava. World J Gastroenterol 16(12):1548–1552

    Article  PubMed  Google Scholar 

  61. Kocaman O, Alponat A, Aygun C et al (2009) Lower gastrointestinal bleeding, hematuria and splenic hemangiomas in Klippel–Trenaunay syndrome: a case report and literature review. Turk J Gastroenterol 20(1):62–6

    PubMed  Google Scholar 

  62. Fakir E, Roberts T, Stephen L et al (2009) Klippel–Trenaunay–Weber syndrome: orodental manifestations and management considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(6):754–8

    Article  PubMed  Google Scholar 

  63. Antoszczyk G, Obtulowicz A, Czarnobilska E et al (2008) Melkersson–Rosenthal syndrome—diagnostic and therapeutic problems. Przegl Lek 65(9):390–392

    PubMed  Google Scholar 

  64. Boh EE (2002) Faleh al-smadei RM: Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin 20(3):533–46

    Article  PubMed  Google Scholar 

  65. Zold E, Nagy A, Devenyi K et al (2009) Successful use of adalimumab for treating fistulizing Crohn’s disease with pyoderma gangrenosum: two birds with one stone. World J Gastroenterol 15(18):2293–5

    Article  PubMed  Google Scholar 

  66. Jorizzo JL (1985) Classification of urticaria and the reactive inflammatory vascular dermatoses. Dermatol Clin 3(1):3–12

    PubMed  CAS  Google Scholar 

  67. White JW (1985) Erythema nodosum. Dermatol Clin 3(1):119–27

    PubMed  Google Scholar 

  68. Philpot HC, Elewski BE, Banwell JG, Gramlich T (1992) Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease. Gastroenterology 103(2):668–74

    PubMed  CAS  Google Scholar 

  69. Loftus EV. Inflammatory bowel disease: extraintestinal manifestations and cancer. In: Mayo clinic gastroenterology and hepatology board review. 3rd ed. Florence: Mayo Clinic Scientific Press, 2008: 218.

  70. Ely PH (1980) The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol 2(6):473–87

    Article  PubMed  CAS  Google Scholar 

  71. Drenick EJ, Ahmed AR, Greenway F et al (1980) Cutaneous lesions after intestinal bypass. Ann Intern Med 93(4):557–9

    Article  PubMed  CAS  Google Scholar 

  72. Patton T, Jukic D, Juhas E (2009) Atypical histopathology in bowel-associated dermatosis–arthritis syndrome: a case report. Dermatol Online J 15(3):3

    PubMed  Google Scholar 

  73. Kang W, Hao C, Nie Q (2009) Clinical challenges and images in GI. Sweet syndrome in association with ulcerative colitis. Gastroenterology 136(5):1507–1846

    Article  PubMed  Google Scholar 

  74. Yuchi H, Yamaga J, Ishikawa N et al (2000) Endoscopic appearance of the GI lesions associated with Sweet’s syndrome. Gastrointest Endosc 52(2):287–9

    Article  PubMed  CAS  Google Scholar 

  75. Bodmer WF, Bailey CJ, Bodmer J et al (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328(6131):614–6

    Article  PubMed  CAS  Google Scholar 

  76. Schwartz RA. Gardner syndrome. In: emedicine.medscape.com/article/1084257-overview.

  77. Tsao H (2000) Update on familial cancer syndromes and the skin. J Am Acad Dermatol 42(6):939–69, quiz 970-2

    Article  PubMed  CAS  Google Scholar 

  78. Lepisto A, Kiviluoto T, Halttunen J et al (2009) Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 41(6):504–9

    Article  PubMed  CAS  Google Scholar 

  79. Schwartz RA, Torre DP (1995) The Muir–Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33(1):90–104

    Article  PubMed  CAS  Google Scholar 

  80. Abbas O, Mahalingam M (2009) Cutaneous sebaceous neoplasms as markers of Muir–Torre syndrome: a diagnostic algorithm. J Cutan Pathol 36(6):613–9

    Article  PubMed  Google Scholar 

  81. Prieto VG. Muir–Torre syndrome. In: emedicine.medscape.com/article/1084257-overview.

  82. Spielvogel RL, DeVillez RL, Roberts LC (1985) Oral isotretinoin therapy for familial Muir–Torre syndrome. J Am Acad Dermatol 12(3):475–480

    Article  PubMed  CAS  Google Scholar 

  83. Graefe T, Wollina U, Schulz H et al (2000) Muir–Torre syndrome—treatment with isotretinoin and interferon alpha-2a can prevent tumor development. Dermatology 200(4):331–333

    Article  PubMed  CAS  Google Scholar 

  84. Starink TM (1984) Cowden’s disease: analysis of fourteen new cases. J Am Acad Dermatol 11(6):1127–41

    Article  PubMed  CAS  Google Scholar 

  85. Liaw D, Marsh DJ, Li J et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16(1):64–67

    Article  PubMed  CAS  Google Scholar 

  86. Schaffer JV, Kamino H, Witkiewicz A et al (2006) Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol 142(5):625–632

    Article  PubMed  Google Scholar 

  87. Requena L, Gutierrez J, Sanchez Yus E (1992) Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden’s disease. J Cutan Pathol 19(4):346–351

    Article  PubMed  CAS  Google Scholar 

  88. Nishizawa A, Satoh T, Watanabe R et al (2009) Cowden syndrome: a novel mutation and overlooked glycogenic acanthosis in gingiva. Br J Dermatol 160(5):1116–8

    Article  PubMed  CAS  Google Scholar 

  89. Squarize CH, Castilho RM, Gutkind JS (2008) Chemoprevention and treatment of experimental Cowden’s disease by mTOR inhibition with rapamycin. Cancer Res 68(17):7066–7072

    Article  PubMed  CAS  Google Scholar 

  90. Moreira AP, Feijo FS, Pinto JM et al (2009) Pseudoxanthoma elasticum. Dermatol Online J 15(1):9

    PubMed  Google Scholar 

  91. Daniel ES, Ludwig SL, Lewin KJ et al (1982) The Cronkhite–Canada syndrome: an analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) 61(5):293–309

    CAS  Google Scholar 

  92. Russell DM, Bhathal PS (1983) St. John DJ: Complete remission in Cronkhite–Canada syndrome. Gastroenterology 85(1):180–5

    PubMed  CAS  Google Scholar 

  93. Ferney DM, DeSchryver-Kecskemeti K, Clouse RE (1986) Treatment of Cronkhite–Canada syndrome with home total parenteral nutrition (letter). Ann Intern Med 104(4):588

    Article  PubMed  CAS  Google Scholar 

  94. Latiff ZA, Atmawidjaja RW, RajaLope RJ et al (2010) Bannayan Riley Ruvalcaba syndrome. AnnAcad Med Singapore 39(7):578–582

    Google Scholar 

  95. Jegher H, McKusick BA, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N Engl J Med 241(26):1037–36

    Article  Google Scholar 

  96. Gammon A, Jsperson K, Kohlmann W et al (2009) Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol 23(2):219–231

    Article  PubMed  CAS  Google Scholar 

  97. Al-Thihli K, Palma L, Marcus V et al (2009) A case of Cowden’s syndrome presenting with gastric carcinomas and gastrointestinal polyposis. Nat Clin Pract Gastroenterol Hepatol 6(3):184–9

    Article  PubMed  Google Scholar 

  98. Harb WJ, Sturgis EM. Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review. Head Neck. 2009 Jun 17. [Epub ahead of print]

  99. Harper PS, Harper RMJ, Howell-Evans AW (1970) Carcinoma of the esophagus with tylosis. Q J Med 39(155):317–33

    PubMed  CAS  Google Scholar 

  100. Beyler AR, Yurdaydin C, Baher K et al (1996) Dilation therapy of upper esophageal webs in two cases of Plummer–Vinson syndrome. Endoscopy 28(2):266–7

    Article  PubMed  CAS  Google Scholar 

  101. Koklu S, Bulut M, Cakal B et al (2009) Gastric cancer presenting with Plummer–Vinson syndrome. J Am Geriatr Soc 57(5):933–4

    Article  PubMed  Google Scholar 

  102. Krawczyk M, Mykala-Ciesla J, Kolodziej-Jaskula A (2009) Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Pol Arch Med Wewn 119(3):180–3

    PubMed  Google Scholar 

  103. Miller JH, Rapini RP. Acanthosis nigricans. In: emedicine.medscape.com/article/1084257-overview.

  104. Cohen PR, Grossman ME, Almeida L et al (1989) Tripe palms and malignancy. J Clin Oncol 7(5):669–78

    PubMed  CAS  Google Scholar 

  105. Ghevariya V, Malieckal A, Ghevariya N et al (2009) Carcinoid tumors of gastrointestinal tract. South Med J 102(10):1032–1040

    Article  PubMed  Google Scholar 

  106. Zeitouni NC, Harvey N. Glucagonoma syndrome. In: emedicine.medscape.com/article/1084257-overview.

  107. Altimari AF, Bhoopalam N, O’Dorsio T et al (1986) Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery 100(6):989–996

    PubMed  CAS  Google Scholar 

  108. Nguyen VQ, Lewin WJ, Raugi GJ. Paraneoplastic diseases. In: emedicine.medscape.com/article/1084257-overview.

  109. Hovenden AL (1993) Hypertrichosis lanuginose acquisita associated with malignancy. Clin Dermatol 11(1):99–106

    Article  PubMed  CAS  Google Scholar 

  110. Saad N, Hot A, Ninet J et al (2007) Acquired hypertrichosis lanuginose and gastric adenocarcinoma. Ann Dermatol Venereol 134(1):55–8

    Article  PubMed  CAS  Google Scholar 

  111. Montemarano AD, Forte GM. Henoch–Schonlein purpura. In: emedicine.medscape.com/article/1084257-overview.

  112. Hogan DJ. Mastrodomenico CM. Mastocytosis. In: emedicine.medscape.com/article/1084257-overview.

  113. Kettelhut BV, Metcalfe DD (1991) Pediatric mastocytosis. J Invest Dermatol 96(3 Suppl):15S–18S, 60S-65S

    Article  Google Scholar 

  114. Lee JK, Whittaker SJ, Enns RA (2008) Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol 14(45):7005–8

    Article  PubMed  Google Scholar 

  115. Swetter SM. Malignant melanoma. In: emedicine.medscape.com/article/1084257-overview.

  116. Schuchter LM, Green R, Fraker D (2000) Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol 12(2):181–5

    Article  PubMed  CAS  Google Scholar 

  117. Ollila DW, Essner R, Wanek LA et al (1996) Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 131(9):975-9–979-80

    Article  Google Scholar 

  118. Drobnik J, Schwartz RA. Hemochromatosis. In: emedicine.medscape.com/article/1084257-overview.

  119. Barton JC, Acton RT (2009) Hemochromatosis and Vibrio vulnifucus wound infections. J Clin Gastroenterol 43(9):890–893

    Article  PubMed  Google Scholar 

  120. Dar FS, Faraj W, Zaman MB et al (2009) Outcome of liver transplantation in hereditary Hemochromatosis. Transpl Int 22(7):717–724

    Article  PubMed  Google Scholar 

  121. Poh-Fitzpatrick MB. Porphyria cutanea tarda: differential diagnoses and workup. In: emedicine.medscape.com/article/1103643-diagnosis.

  122. Herrero C, Vicente A, Bruguera M et al (1993) Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 341(8848):788–9

    Article  PubMed  CAS  Google Scholar 

  123. Tsukazaki N, Watanable M, Irifune H et al (1998) Porphyria cutanea tarda and hepatitis C virus infection. Br J Dermatol 138(6):1015–7

    Article  PubMed  CAS  Google Scholar 

  124. Nunley JR. Dermatiologic manifestations of renal disease. In: emedicine.medscape.com/article/1084257-overview.

  125. Kosmin DJ, Jackson JM. Polyarteritis nodosa. In: emedicine.medscape.com/article/1084257-overview.

  126. Ebert EC, Hagspiel KD, Nagar M et al (2008) Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol 6(9):960–6

    Article  PubMed  Google Scholar 

  127. Zone J (2005) Skin manifestations of celiac disease. Gastroenterology 128(4 Suppl 1):S87–91

    Article  PubMed  Google Scholar 

  128. Miller JL. Dermatitis herpetiformis. In: emedicine.medscape.com/article/1084257-overview.

  129. Abenavoli L, Proietti I, Leggio L (2006) Cutaneous manifestations in celiac disease. World J Gastroenterol 12(6):843–52

    PubMed  CAS  Google Scholar 

  130. Jen M, Shah KN, Yan AC (2008) Cutaneous changes in nutritional diseases. In: Wolff K, Goldsmith LA, Katz SI et al (eds) Fitzpatrick’s Dermatology in general medicine, 7th edn. McGraw Hill, New York, pp 1209–16

    Google Scholar 

  131. Kumar P, Lal NR, Mondal AK, Mondal A, Gharami RC, Maiti A (2012) Zinc and skin: a brief summary. Dermatol Online J 18(3):1

    PubMed  Google Scholar 

  132. Wapnir RA (2000) Zinc deficiency, malnutrition and the gastrointestinal tract. J Nutr 130(5S Suppl):1388S–92S

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Elmhurst Hospital Center, Mount Sinai School of Medicine, 79-01 Broadway, Elmhurst, NY, 11373, USA

    Vishal Ghevariya

  2. Division of Gastroenterology, The Brooklyn Hospital Center, 121 Dekalb Ave, Brooklyn, NY, 11201, USA

    Shashideep Singhal & Sury Anand

Authors
  1. Vishal Ghevariya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shashideep Singhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sury Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vishal Ghevariya.

Additional information

This is to certify that all authors had meaningful participation in preparation of this manuscript and all authors acknowledge and agree with submission to this journal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghevariya, V., Singhal, S. & Anand, S. The skin: a mirror to the gut. Int J Colorectal Dis 28, 889–913 (2013). https://doi.org/10.1007/s00384-012-1637-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-012-1637-x

Keywords

Search

Navigation